Literature DB >> 12676765

Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease.

Sam Afshar1, Linda L Gibson, Ivan S Yuhanna, Todd S Sherman, Jay D Kerecman, Peter H Grubb, Bradley A Yoder, Donald C McCurnin, Philip W Shaul.   

Abstract

Nitric oxide (NO), produced by NO synthase (NOS), serves multiple functions in the perinatal lung. In fetal baboons, neuronal (nNOS), endothelial (eNOS), and inducible NOS (iNOS) are all primarily expressed in proximal respiratory epithelium. In the present study, NOS expression and activity in proximal lung and minute ventilation of NO standard temperature and pressure (VeNO(STP)) were evaluated in a model of chronic lung disease (CLD) in baboons delivered at 125 days (d) of gestation (term = 185 d) and ventilated for 14 d, obtaining control lung samples from fetuses at 125 or 140 d of gestation. In contrast to the normal 73% increase in total NOS activity from 125 to 140 d of gestation, there was an 83% decline with CLD. This was related to marked diminutions in both nNOS and eNOS expression and enzymatic activity. nNOS accounted for the vast majority of enzymatic activity in all groups. The normal 3.3-fold maturational rise in iNOS protein expression was blunted in CLD, yet iNOS activity was elevated in CLD compared with at birth. The contribution of iNOS to total NOS activity was minimal in all groups. VeNO(STP) remained stable in the range of 0.5-1.0 nl x kg(-1) x min(-1) from birth to day 7 of life, and it then rose by 2.5-fold. Thus the baboon model of CLD is characterized by deficiency of the principal pulmonary isoforms, nNOS and eNOS, and enhanced iNOS activity over the first 2 wk of postnatal life. It is postulated that these alterations in NOS expression and activity may contribute to the pathogenesis of CLD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676765     DOI: 10.1152/ajplung.00334.2002

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  34 in total

Review 1.  Chronic lung disease in the preterm infant. Lessons learned from animal models.

Authors:  Anne Hilgendorff; Irwin Reiss; Harald Ehrhardt; Oliver Eickelberg; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

2.  Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs.

Authors:  Richard D Bland; Kurt H Albertine; David P Carlton; Amy J MacRitchie
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

3.  Pulmonary hypertension in premature infants. Sharpening the tools of detection.

Authors:  Kathryn N Farrow; Robin H Steinhorn
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

Review 4.  Can We Understand the Pathobiology of Bronchopulmonary Dysplasia?

Authors:  Cristina M Alvira; Rory E Morty
Journal:  J Pediatr       Date:  2017-11       Impact factor: 4.406

Review 5.  Role of reactive oxygen species in neonatal pulmonary vascular disease.

Authors:  Stephen Wedgwood; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 6.  Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.

Authors:  Nicolas F M Porta; Robin H Steinhorn
Journal:  Clin Perinatol       Date:  2012-03       Impact factor: 3.430

7.  Sildenafil therapy for bronchopulmonary dysplasia: not quite yet.

Authors:  K N Farrow; R H Steinhorn
Journal:  J Perinatol       Date:  2012-01       Impact factor: 2.521

Review 8.  Pharmacotherapy for pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

Review 9.  Progress in understanding the pathogenesis of BPD using the baboon and sheep models.

Authors:  Kurt H Albertine
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

Review 10.  Pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Sara K Berkelhamer; Karen K Mestan; Robin H Steinhorn
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.